Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Short term Debt (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Short term Debt for 10 consecutive years, with $15.3 million as the latest value for Q4 2025.

  • Quarterly Short term Debt changed N/A to $15.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.3 million through Dec 2025, changed N/A year-over-year, with the annual reading at $15.3 million for FY2025, N/A changed from the prior year.
  • Short term Debt hit $15.3 million in Q4 2025 for STRATA Skin Sciences, up from $1.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $15.3 million in Q4 2025 to a low of $3000.0 in Q2 2021.